Tx of Postnatal Depression Tied to Better Maternal, Offspring Outcomes
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 31, 2023 -- Postnatal selective serotonin reuptake inhibitor (SSRI) treatment is associated with long-term benefits for women with postnatal depression and their offspring, according to a study published online Aug. 29 in JAMA Network Open.
Chaoyu Liu, M.D., Ph.D., from King’s College in London, and colleagues examined whether postnatal SSRI treatment moderated postnatal depression-associated maternal and child outcomes across the early childhood years. The analysis included 61,081 mother-child dyads.
The researchers found that 14.2 percent of mothers met the criteria for postnatal depression diagnosis, with 2.0 percent receiving postnatal SSRI treatment. More severe postnatal depression symptoms were associated with a range of adverse maternal and child outcomes. Postnatal SSRI treatment lessened negative associations between postnatal depression and maternal relationship satisfaction at postpartum month 6 (moderation β, 0.13), year 1.5 (moderation β, 0.11), and year 3 (moderation β, 0.12). Postnatal SSRI treatment also lessened negative associations with child attention-deficit/hyperactivity disorder at age 5 years (moderation β, −0.15). Negative associations between postnatal depression and maternal depression, partner relationship satisfaction, and child externalizing problems were mitigated with postnatal SSRI treatment.
“This study potentially provides valuable information for clinicians and women with postnatal depression to make informed treatment decisions,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Risk of Suicide, Homicide Both Higher at Night
FRIDAY, June 7, 2024 -- The risk of suicide and homicide is higher at night than might be expected based on the number of people awake at that time, according to a study published...
Social Media Use Tied to Depression, but Not Sole Cause in Young Adults
FRIDAY, June 7, 2024 -- Social media use and depression are associated, but social media use is not prospectively related to the course of depressive symptoms, according to a...
Many Patients Have Discontinuation Symptoms After Stopping Antidepressants
THURSDAY, June 6, 2024 -- A considerable proportion of patients have discontinuation symptoms (e.g., dizziness, headache, nausea, insomnia, and irritability) after...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.